Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -0.38% is 93% above its 5-year average of -5.51%, near the high end of its 5-year range (-52.72%–7.26%).
As of the fiscal period ended Sunday, May 31, 2026. 98.82% above its 12-month average of -31.99%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-05-31): -0.38%.
RETURN ON EQUITY (ROE)
-0.38%
RETURN ON EQUITY (ROE) AVG TTM
-31.99%
RETURN ON EQUITY (ROE) AVG 3Y
-15.25%
RETURN ON EQUITY (ROE) AVG 5Y
-5.51%
RETURN ON EQUITY (ROE) AVG 10Y
6.25%
RETURN ON EQUITY (ROE) AVG 15Y
7.65%
RETURN ON EQUITY (ROE) AVG 20Y
9.73%
CURRENT VS TTM AVG
+98.82%
CURRENT VS 3Y AVG
+97.53%
CURRENT VS 5Y AVG
+93.16%
CURRENT VS 10Y AVG
-106.03%
CURRENT VS 15Y AVG
-104.93%
CURRENT VS 20Y AVG
-103.87%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+99.10%
vs the sector median at left
Neogen Corporation
Market Cap
$2.61B
Return on Equity (ROE)
-0.38%
TTM Avg
-31.99%
3Y Avg
-15.25%
5Y Avg
-5.51%
Market Cap
$2.58B
Return on Equity (ROE)
-8.00%
TTM Avg
-28.91%
3Y Avg
-27.68%
5Y Avg
-39.13%
Market Cap
$2.65B
Return on Equity (ROE)
95.64%
TTM Avg
115.72%
3Y Avg
76.74%
5Y Avg
3213.80%
Market Cap
$2.56B
Return on Equity (ROE)
0.00%
TTM Avg
2.68%
3Y Avg
1.94%
5Y Avg
-2.51%
Market Cap
$2.66B
Return on Equity (ROE)
-25.47%
TTM Avg
-23.80%
3Y Avg
14.67%
5Y Avg
14.67%
Market Cap
$2.67B
Return on Equity (ROE)
-56.91%
TTM Avg
-24.13%
3Y Avg
-9.83%
5Y Avg
-11.19%
Market Cap
$2.53B
Return on Equity (ROE)
-41.10%
TTM Avg
-30.86%
3Y Avg
-32.08%
5Y Avg
-34.60%
Market Cap
$2.70B
Return on Equity (ROE)
-361.91%
TTM Avg
-763.19%
3Y Avg
-396.22%
5Y Avg
-320.76%
Market Cap
$2.73B
Return on Equity (ROE)
2.04%
TTM Avg
-6.01%
3Y Avg
-7.18%
5Y Avg
-5.00%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neogen Corporation (NEOG) | $2.61B | -0.38% | -31.99% | -15.25% | -5.51% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.58B | -8.00% | -28.91% | -27.68% | -39.13% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.65B | 95.64% | 115.72% | 76.74% | 3213.80% |
| Privia Health Group, Inc. (PRVA)vs › | $2.56B | 0.00% | 2.68% | 1.94% | -2.51% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.66B | -25.47% | -23.80% | 14.67% | 14.67% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.67B | -56.91% | -24.13% | -9.83% | -11.19% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.53B | -41.10% | -30.86% | -32.08% | -34.60% |
| Precigen, Inc. (PGEN)vs › | $2.70B | -361.91% | -763.19% | -396.22% | -320.76% |
| AtriCure, Inc. (ATRC)vs › | $2.73B | 2.04% | -6.01% | -7.18% | -5.00% |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.47B | -10.66% | 1.75% | 2.62% | 5.68% |
ROE
-0.4%
ROA
-0.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-05-31 | -0.38% |
| 2026-02-28 | -28.96% |
| 2025-11-30 | -28.64% |
| 2025-08-31 | -49.23% |
| 2025-05-31 | -52.72% |
| 2025-02-28 | -18.24% |
| 2024-11-30 | -17.85% |
| 2024-08-31 | -0.75% |
| 2024-05-31 | -0.30% |
| 2024-02-29 | 0.05% |
| 2023-11-30 | 0.37% |
| 2023-08-31 | -0.84% |
| 2023-05-31 | -0.73% |
| 2023-02-28 | -0.43% |
| 2022-11-30 | -0.52% |
| 2022-08-31 | 4.12% |
| 2022-05-31 | 5.44% |
| 2022-02-28 | 5.61% |
| 2021-11-30 | 6.59% |
| 2021-08-31 | 7.26% |
| 2021-05-31 | 7.24% |
| 2021-02-28 | 7.61% |
| 2020-11-30 | 7.76% |
| 2020-08-31 | 8.07% |
| 2020-05-31 | 8.20% |
| 2020-02-29 | 8.28% |
| 2019-11-30 | 8.66% |
| 2019-08-31 | 9.02% |
| 2019-05-31 | 9.43% |
| 2019-02-28 | 9.99% |
| 2018-11-30 | 10.87% |
| 2018-08-31 | 11.43% |
| 2018-05-31 | 11.27% |
| 2018-02-28 | 10.72% |
| 2017-11-30 | 9.94% |
| 2017-08-31 | 9.40% |
| 2017-05-31 | 9.28% |
| 2017-02-28 | 9.12% |
| 2016-11-30 | 9.02% |
| 2016-08-31 | 8.90% |
| 2016-05-31 | 9.05% |
| 2016-02-29 | 9.30% |
| 2015-11-30 | 9.32% |
| 2015-08-31 | 9.28% |
| 2015-05-31 | 9.55% |
| 2015-02-28 | 9.41% |
| 2014-11-30 | 9.43% |
| 2014-08-31 | 9.16% |
| 2014-05-31 | 9.19% |
| 2014-02-28 | 9.50% |
| 2013-11-30 | 9.84% |
| 2013-08-31 | 10.46% |
| 2013-05-31 | 10.53% |
| 2013-02-28 | 10.66% |
| 2012-11-30 | 10.42% |
| 2012-08-31 | 10.13% |
| 2012-05-31 | 10.28% |
| 2012-02-29 | 10.69% |
| 2011-11-30 | 10.90% |
| 2011-08-31 | 11.71% |
| 2011-05-31 | 12.11% |
| 2011-02-28 | 12.06% |
| 2010-11-30 | 11.92% |
| 2010-08-31 | 11.78% |
| 2010-05-31 | 11.48% |
| 2010-02-28 | 11.14% |
| 2009-11-30 | 10.76% |
| 2009-08-31 | 10.78% |
| 2009-05-31 | 10.78% |
| 2009-02-28 | 10.92% |
| 2008-11-30 | 11.14% |
| 2008-08-31 | 11.03% |
| 2008-05-31 | 10.87% |
| 2008-02-29 | 10.65% |
| 2007-11-30 | 10.38% |
| 2007-08-31 | 10.11% |
| 2007-05-31 | 9.92% |
| 2007-02-28 | 9.97% |
| 2006-11-30 | 9.86% |
| 2006-08-31 | 9.89% |
| 2006-05-31 | 12.30% |
| 2006-02-28 | 12.05% |
| 2005-11-30 | 11.75% |
| 2005-08-31 | 11.31% |
| 2005-05-31 | 10.79% |
| 2005-02-28 | 10.39% |
| 2004-11-30 | 10.66% |
| 2004-08-31 | 10.81% |
| 2004-05-31 | 10.66% |
| 2004-02-29 | 11.41% |
| 2003-11-30 | 11.48% |
| 2003-08-31 | 11.70% |
| 2003-05-31 | 11.56% |
